Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating interleukin-15 after chemotherapy and lymphocyte transfer in metastatic melanoma; the study was terminated and re…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery [Phase 1]
A Phase 1 trial evaluated whether a booster vaccination could prevent recurrence of surgically removed melanoma in patients who had prior va…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma. [Phase 1, Phase 2]
This Clinical Trial Update reports the completion of an open-label Phase I/IIa dose-escalation study of 2B3-101 in patients with solid tumor…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma [Phase 2]
Phase II trial investigating extended-dosing temozolomide in melanoma completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma [Phase 1, Phase 2]
A clinical trial update for a phase 1/2 study of a recombinant vaccinia virus (Pexa-Vec/JX-594) in malignant melanoma, sponsored by Jennerex…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of sulindac and epirubicin for metastatic melanoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma [Phase 2]
Phase 2 clinical trial evaluating a melanoma vaccine with or without sargramostim in patients with stage IIB through IV melanoma; the study …
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating imatinib mesylate for patients with unresectable stage III or stage IV melanoma, including acral lentigino…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial evaluated the combination of RO4929097, a gamma-secretase inhibitor, with Cediranib maleate in adults with advanced solid…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Pilot Study of Infrared Imaging of Cutaneous Melanoma
A pilot trial evaluating infrared imaging for detecting cutaneous melanoma has been completed, conducted by the University of Virginia.
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases [Phase 2]
Phase 2 trial update of Yttrium-90 glass microsphere radioembolization (TheraSphere) for patients with liver metastases, completed with resu…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]
This Phase 2 trial evaluating a vaccine therapy for unresectable stage III/IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluating a vaccine therapy in combination with interleukin-2 for stage III or IV melanoma has completed and results have b…
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating laboratory-treated autologous lymphocytes with Aldesleukin after cyclophosphamide and fludarabine in metastatic m…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma [Phase 3]
Phase 3 trial comparing dabrafenib plus trametinib versus vemurafenib alone in unresectable or metastatic BRAF V600E/K cutaneous melanoma ha…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Intratumoral Application of L19IL2 in Patients With Malignant Melanoma [Phase 2]
Phase 2 trial update on intratumoral delivery of L19IL2 in patients with melanoma; the Phase 2 study has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 1]
This Phase 1 clinical trial evaluated a vaccine therapy in patients with metastatic melanoma and has completed; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma [Phase 1, Phase 2]
Completed Phase 1/2 trial testing a vaccine therapy in patients with advanced melanoma, including skin melanoma and intraocular melanoma.
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Does the Aid of MelaFind Affect Clinical Management Decisions
This clinical trial evaluated whether using MelaFind as an aid affects clinical management decisions for melanoma; results were posted on 20…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes [Phase 2]
A Phase 2 trial evaluated high-resolution MRI to detect melanoma spread to nearby lymph nodes, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Lovastatin in Treating Patients At High Risk of Melanoma [Phase 2]
Phase 2 clinical trial evaluating lovastatin in people at high risk of developing melanoma; the study is completed and results were posted i…
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery [EARLY_Phase 1]
An early-phase clinical trial evaluating the combination of a vaccine therapy with resiquimod as adjuvant treatment in patients with surgica…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma [Phase 2]
A Phase 2 trial of vorinostat in patients with metastatic or unresectable melanoma has completed, with results posted in 2014. The study enc…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Evaluation of a Simulation Training Tool to Identify Lesions Requiring Further Screening for Melanoma [NA]
This clinical trial update reports the completed evaluation of a simulation-based training tool designed to improve visual screening for mel…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery [Phase 1]
This Phase 1 trial evaluating cabozantinib-s-malate in combination with vemurafenib for metastatic or unresectable solid tumors and melanoma…